196 related articles for article (PubMed ID: 30209337)
1. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
[TBL] [Abstract][Full Text] [Related]
2. Intracranial meningioma: Experience with stereotactic radiotherapy.
Ragos V; Yazici O; Guzle Adas Y; Kekilli E; Calikoglu T; Bedri Altundag M; Riza Ucer A; Ertas G; Durmus Duzgun S; Ozbagi K; Demirkasimoglu A; Demir E; Aslan B; Kaya B
J BUON; 2018; 23(4):1169-1173. PubMed ID: 30358227
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
5. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
[TBL] [Abstract][Full Text] [Related]
6. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy for intracranial meningiomas: preliminary results of a feasible trial.
Trippa F; Maranzano E; Costantini S; Giorni C
J Neurosurg Sci; 2009 Mar; 53(1):7-11. PubMed ID: 19322130
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery versus stereotactic radiotherapy in the management of intracranial meningiomas: a systematic review and meta-analysis.
Fatima N; Meola A; Pollom EL; Soltys SG; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E2. PubMed ID: 31153149
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
10. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
[TBL] [Abstract][Full Text] [Related]
12. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.
Koide Y; Tomita N; Adachi S; Tanaka H; Tachibana H; Kodaira T
Nagoya J Med Sci; 2019 Aug; 81(3):397-406. PubMed ID: 31579330
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.
Maranzano E; Draghini L; Casale M; Arcidiacono F; Anselmo P; Trippa F; Giorgi C
Strahlenther Onkol; 2015 Dec; 191(12):953-60. PubMed ID: 26490452
[TBL] [Abstract][Full Text] [Related]
16. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
18. HFSRT of the resection cavity in patients with brain metastases.
Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated stereotactic radiotherapy (HFSRT) for who grade I anterior clinoid meningiomas (ACM).
Demiral S; Dincoglan F; Sager O; Gamsiz H; Uysal B; Gundem E; Elcim Y; Dirican B; Beyzadeoglu M
Jpn J Radiol; 2016 Nov; 34(11):730-737. PubMed ID: 27659448
[TBL] [Abstract][Full Text] [Related]
20. Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma.
Kaul D; Budach V; Wurm R; Gruen A; Graaf L; Habbel P; Badakhshi H
Radiat Oncol; 2014 Mar; 9():78. PubMed ID: 24650090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
